The results of a survey of physicians published today in Infection Control and Hospital Epidemiology indicate that when treating patients at the end of life, physicians' decisions about continuing antimicrobial use are influenced by many factors.
The World Economic Forum's 2018 Global Risks Report, released this week, includes a section on antimicrobial resistance (AMR), noting that while initiatives to address antibiotic overuse and the lack of new antibiotics have been launched, concrete successes "remain elusive."
Few resources address when contact precautions can be stepped back, and hospital approaches vary.
Scientists from Italy today reported detecting the worrisome colistin-resistance gene MCR-4 in two isolates of Salmonella from people, only the second time the gene has been reported and the first time in humans, according to their report in Eurosurveillance.
The Defense Threat Reduction Agency, a division of the US Department of Defense, has awarded up to $16 million to VenatoRx Pharmaceuticals for discovery and development of a novel, first-in-class antibiotic for biodefense applications.
Data from high-quality, randomized controlled trials show that bactericidal antibiotics are not intrinsically superior to bacteriostatic antibiotics, researchers from the University of Southern California School of Medicine report in a new paper in Clinical Infectious Diseases.
A 2007 state law in Illinois mandating active surveillance of methicillin-resistant Staphylococcus aureus (MRSA) in intensive care unit (ICU) patients failed to reduce MRSA prevalence, according to a study yesterday in Clinical Infectious Diseases.
The drug-resistant strain has emerged recently on pig farms but has rarely caused human illness.
Hong Kong's Centre for Health Protection (CHP) this week launched an Antibiotic Stewardship Program (ASP) in Primary Care and hospital guidelines on multidisciplinary prescribing as two key steps in rolling out the Hong Kong Strategy and Action Plan on Antimicrobial Resistance (AMR).
The report shows increasing trends in several bacteria, most notably in rates of combined resistance for E coli.
